Latest / PETRI DISH PERSPECTIVES
Episode 45: BioMarin
Send us Fan Mail
Most biotech companies chase massive markets. But BioMarin Pharmaceutical built its entire strategy around something very different: ultra-rare genetic diseases affecting only small patient populations around the world.
In this episode of Petri Dish Perspectives: Biotech Unleashed, we break down how BioMarin became one of the most influential rare-disease biotech companies in the industry. We explore the company’s founding vision, the scientific pathways behind its major therapies, and how its team translated academic discoveries into real treatments for patients with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.